Incyte | INCY - Stock

Aktienkurs
98.18
Täglich Wechseln
-0.92 -0.93%
Monatlich
4.31%
Jährlich
58.28%
Q2 Prognose
92.62




Stock Veränderung Datum
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.22B 121M 2025-12
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Exelixis USD 27.4M 3.92M 2025-09
Gilead Sciences USD 1.77B 11M 2025-12
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
MacroGenics USD 7.91M 840K 2025-12
Merck USD 6.66B 214M 2025-12
Moderna USD 332M 92M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.27B 152M 2025-12
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12